Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy: a randomized, controlled, prospective study

References

• The Guideline Committee of the Japanese Society for Helicobacter Research. Guidelines for diagnosis and treatment. Helicobacter Res 2000;4:444–54.
   Google Scholar
• Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R, Axon A, Current concepts in the management of Helicobacter pylori infection – the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002;16:167–80.
   PubMed Web of Science ®Google Scholar
• Higuchi K, Fujiwara Y, Tominaga K, Watanabe T, Shiba M, Nakamura S, Is eradication sufficient to heal gastric ulcers in patients infected with Helicobacter pylori? A randomized, controlled, prospective study. Aliment Pharmacol Ther 2003;17:111–17.
   PubMed Web of Science ®Google Scholar
• Iijima K, Ohara S, Sekine H, Koike T, Kato K, Asaki S, Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut 2000;46:20–6.
   PubMed Web of Science ®Google Scholar
• Hiraishi H, Haruma K, Miwa H, Goto H. Clinical Trial: Irsogladine maleate, a mucosal protective drug, accelerates gastric ulcer healing after treatment for eradication of Helicobacter pylori infection; results of a multicentre, double-blind, randomised clinical trial (IMPACT study). Aliment Pharmacol Ther 2010;31:824–33.
   PubMedGoogle Scholar
• Kyoi T, Oka M, Noda K, Ukai Y. Irsogladine prevents monochloramine-induced gastric mucosal lesions by improving the decrease in mucosal blood flow due to the disturbance of nitric oxide synthesis in rats. J Pharmacol Sci 2003;93:314–20.
   PubMedGoogle Scholar
• Tatsumi Y, Tanino M, Kodama T, Kashima K, Katsura M, Okuma S. Irsogladine maleate may preserve gastric mucosal hydrophobicity against ethanol in phospholipids independent way in rats. Jpn J Pharmacol 1998;77:293–9.
   PubMedGoogle Scholar
• Kyoi T, Kitazawa S, Tajima K, Zhang X, Ukai Y. Phosphodiesterase type IV inhibitors prevent ischemia-reperfusion-induced gastric injury in rats. J Pharmacol Sci 2004;95:321–8.
   PubMedGoogle Scholar
• Zhang X, Tajima K, Kageyama K, Kyoi T. Irsogladine maleate suppresses indomethacin-induced elevation of proinflammatory cytokines and gastric injury in rats. World J Gastroenterol 2008;14:4784–90.
   PubMedGoogle Scholar
• Ueda F, Kameda Y, Yamamoto O, Shibata Y. Beta-adrenergic regulation of gap-junctional intercellular communication in cultured rabbit gastric epithelial cells. J Pharmacol Exp Ther 1994;271:397–402.
   PubMed Web of Science ®Google Scholar
• Sato M, Manabe N, Hata J, Ishii M, Kamada T, Kusunoki H, Effect of irsogladine maleate on NSAID-induced reduction of gastric mucosal blood flow in anesthetized dogs. Digestion 2009;79:73–8.
   PubMedGoogle Scholar
• Kyoi T, Noda K, Oka M, Ukai Y. Irsogladine, an anti-ulcer drug, suppresses superoxide production by inhibiting phosphodiesterase type 4 in human neutrophils. Life Sci 2004;76:71–83.
   PubMedGoogle Scholar
• Kyoi T, Oka M, Noda K, Ukai Y. Phosphodiesterase inhibition by a gastroprotective agent irsogladine: preferential blockade of cAMP hydrolysis. Life Sci 2004;75:1833–42.
   PubMedGoogle Scholar
• Murakami K, Sato R, Okimoto T, Watanabe K, Nasu M, Kodama M, Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial. J Gastroenterol Hepatol 2006;21:1048–53.
   PubMedGoogle Scholar
• Knoll MR, Kolbel CB, Teyssen S, Singer MV. Action of pure ethanol and some alcoholic beverages on the gastric mucosa in healthy humans: a descriptive endoscopic study. Endoscopy 1998;30:293–301.
   PubMedGoogle Scholar
• Miwa H, Sakaki N, Sugano K, Sekine H, Higuchi K, Uemura N, Recurrent peptic ulcers in patients following successful Helicobacter pylori eradication: a multicenter study of 4940 patients. Helicobacter 2004;9:9–16.
   PubMedGoogle Scholar
• Mustonen H, Kiviluoto T, Paimela H, Puolakkainen P, Kivilaakso E. Calcium signaling is involved in ethanol-induced volume decrease and gap junction closure in cultured rat gastric mucosal cells. Dig Dis Sci 2005;50:103–10.
   Web of Science ®Google Scholar
• Mustonen H, Kiviluoto T, Puolakkainen P, Kivilaakso E. Ethanol induces volume changes and gap junction closure via intracellular Ca2+ signalling pathway in cultured rabbit gastric epithelial cells. Scand J Gastroenterol 2004;39:104–10.
   PubMed Web of Science ®Google Scholar
• Kameda Y, Ueda F. Irsogladine inhibits ionomycin-induced decrease in intercellular communication in cultured rabbit gastric epithelial cells. Jpn J Pharmacol 1995;69:223–8.
   PubMedGoogle Scholar
• Debas HT, Cohen MM, Holubitsky IB, Harrison RC. Effect of cigarette smoking on human gastric secretory responses. Gut 1971;12:93–6.
   PubMed Web of Science ®Google Scholar
• Muller-Lissner SA. Bile reflux is increased in cigarette smokers. Gastroenterology 1986;90:1205–9.
   PubMed Web of Science ®Google Scholar
• Reynolds JC, Schoen RE, Maislin G, Zangari GG. Risk factors for delayed healing of duodenal ulcers treated with famotidine and ranitidine. Am J Gastroenterol 1994;89:571–80.
   PubMedGoogle Scholar
• Chujoh C, Nakazawa S. Experimental study for the gastric mucosal damage–especially, the effect of cigarette smoking on the healing course of acetic acid ulcer in rats (author's transl). Jpn J Gastroenterol 1981;78:2285–94.
   PubMedGoogle Scholar
• Sonnenberg A, Husmert N. Effect of nicotine on gastric mucosal blood flow and acid secretion. Gut 1982;23:532–5.
   PubMed Web of Science ®Google Scholar
• Kawano S, Sato N, Fukuda M, Shichiri M, Kamada T, Abe H. Effect of cigarette smoking on the gastric hemodynamics. Analysis by reflectance spectrophotometry (author's transl). Jpn J Gastroenterol 1982;79:187–92.
   PubMedGoogle Scholar